Acorda Therapeuticsincis A Biopharmaceutical Company Established In 1995Headquartered In Pearl Rivernew Yorkwith An Additional Presence In Ardsleynew Yorkthe Company Specializes In Developing And Commercializing Therapies For Neurological Disordersoperating Within The Drug Manufacturing Sector Acorda S Product Portfolio Includes Ampyradalfampridine An Oral Medication That Helps Improve Walking In Adults With Multiple Sclerosisand Inbrijaan Inhaled Levodopa Formulation For Treating Off Episodes In Parkinsonae S Disease Patientsthe Company Distributes Its Products Through Wholesale Pharmaceutical Distributors To Retail Pharmacies And Specialty Pharmacy Providersprimarily Serving Healthcare Providers And Patients With Neurological Conditionsacorda Has A Collaboration Agreement With Biogen Incfor The Development And Commercialization Of Ampyra
